Strides Pharma Science has informed that the Board of Directors of the Company in their meeting held on 8-01-2020 have approved the appointment of R Ananthanarayanan (DIN: 02231540) as Chief Executive Officer & Managing Director of the Company effective January 9, 2020, for a period of 5 years, subject to approval of the Members of the Company. Further, he is also appointed as Key Managerial Personnel of the Company effective January 9, 2020. Disclosure under Regulation 30 of the SEBI Listing Regulations for the said appointment is enclosed as Annexure. The Company also approved re-designation of Arun Kumar (DIN: 00084845) as Executive Director effective January 9, 2020.
The above information is a part of company’s filings submitted to BSE.
